ANZUPGO 20 mg/g, cream tube, 60 g
Active ingredients: Delgocitinib
Commercialized according to BDPMDispensing in France: Prescription only
Creamtube, 60 gcutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ANZUPGO 20 mg/g, crème
- Pharmaceutical form
- crème
- Route of administration
- cutanée
- Presentation description
- 1 tube(s) laminé polyéthylène basse densité (PEBD) de 60 g
- Marketing authorisation holder
- LEO PHARMA A/S (DANEMARK)
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 2 Jun 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61015604CIP73030309CIP133400930303092Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DELGOCITINIBcrème | 20 mg · 1 g de crème | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.